Subscribe

December 2018, Vol 8, No 12

Researchers Identify First Mutation to Explain Resistance to Venetoclax
By Phoebe Starr
The BCL2 Gly101Val mutation is the first genomic alteration to be identified as responsible for resistance to venetoclax (Venclexta), a potent and effective medication indicated for the treatment of chronic lymphocytic leukemia. Read More ›
Harnessing the Power of Data Collection and Coordination in Oncology Practice
By Meg Barbor, MPH
Practice Management
Business intelligence is the process of collecting data from disparate systems—internal and external—and turning it into information that is meaningful and actionable toward achieving strategic goals. Read More ›
MIPS: How to Be Successful Today and in the Future
By Toni Gress
Practice Management
The McKesson value-based care team employs a combination of tactics to help practices in The US Oncology Network achieve success in the Merit-Based Incentive Payment System (MIPS). One of the challenges with the new MIPS program is the need to focus on the current year’s performance, while taking steps to ensure that practices are successful in future years. Read More ›

Page 1 of 2

  • 1
  • 2
CONNECT
Subscribe
Sign Up for Oncology News

Subscribe to recieve the free, monthly OPM print publication and OPM weekly e‑newsletter.

Subscribe
© Amplity Health. All Rights Reserved. Privacy Policy.